Literature DB >> 18713727

Interleukin-10 inhibits tumor necrosis factor-alpha production in lipopolysaccharide-stimulated RAW 264.7 cells through reduced MyD88 expression.

Jargalsaikhan Dagvadorj1, Yoshikazu Naiki, Gantsetseg Tumurkhuu, Ferdaus Hassan, Shamima Islam, Naoki Koide, Isamu Mori, Tomoaki Yoshida, Takashi Yokochi.   

Abstract

The mechanism of interleukin (IL)-10-mediated inhibition of tumor necrosis factor (TNF)-alpha production was studied by lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophage cells. IL-10 inhibited TNF-alpha production transiently at an early stage after LPS stimulation. IL-10 inhibited the activation of nuclear factor (NF)-kappaB, p38 and stress-activated protein kinase (SAPK) in LPS-stimulated RAW 264.7 cells. Although the level of MyD88 protein increased in response to LPS, IL-10 prevented the LPS-induced MyD88 augmentation. There was no significant difference in the MyD88 mRNA expression between the cells pretreated with or without IL-10 in response to LPS. Therefore, IL-10 was suggested to inhibit LPS-induced TNF-alpha production via reduced MyD88 expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18713727     DOI: 10.1177/1753425908089618

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  12 in total

Review 1.  Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS?

Authors:  Catherine E Downes; Peter J Crack
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 2.  Macrophages make me sick: how macrophage activation states influence sickness behavior.

Authors:  Morgan L Moon; Leslie K McNeil; Gregory G Freund
Journal:  Psychoneuroendocrinology       Date:  2011-08-19       Impact factor: 4.905

3.  PPAR-γ/IL-10 axis inhibits MyD88 expression and ameliorates murine polymicrobial sepsis.

Authors:  Ana Elisa Ferreira; Flavia Sisti; Fabiane Sônego; Suojuan Wang; Luciano Ribeiro Filgueiras; Stephanie Brandt; Ana Paula Moreira Serezani; Hong Du; Fernando Q Cunha; Jose Carlos Alves-Filho; Carlos Henrique Serezani
Journal:  J Immunol       Date:  2014-01-31       Impact factor: 5.422

4.  Synthetic mimics of antimicrobial peptides with immunomodulatory responses.

Authors:  Hitesh D Thaker; Abhigyan Som; Furkan Ayaz; Dahui Lui; Wenxi Pan; Richard W Scott; Juan Anguita; Gregory N Tew
Journal:  J Am Chem Soc       Date:  2012-06-27       Impact factor: 15.419

5.  Single-cell secretion analysis reveals a dual role for IL-10 in restraining and resolving the TLR4-induced inflammatory response.

Authors:  Amanda F Alexander; Ilana Kelsey; Hannah Forbes; Kathryn Miller-Jensen
Journal:  Cell Rep       Date:  2021-09-21       Impact factor: 9.423

Review 6.  Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.

Authors:  Ankit Saxena; Sam Khosraviani; Sanjeev Noel; Divya Mohan; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cytokine       Date:  2014-12-04       Impact factor: 3.861

Review 7.  An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection.

Authors:  Tsung-Ting Tsai; Yi-Jui Chuang; Yee-Shin Lin; Shu-Wen Wan; Chia-Ling Chen; Chiou-Feng Lin
Journal:  J Biomed Sci       Date:  2013-06-25       Impact factor: 8.410

8.  An Appropriate Modulation of Lymphoproliferative Response and Cytokine Release as Possible Contributors to Longevity.

Authors:  Irene Martínez de Toda; Carmen Vida; Mónica De la Fuente
Journal:  Int J Mol Sci       Date:  2017-07-24       Impact factor: 5.923

9.  Multi-scale modeling predicts a balance of tumor necrosis factor-α and interleukin-10 controls the granuloma environment during Mycobacterium tuberculosis infection.

Authors:  Nicholas A Cilfone; Cory R Perry; Denise E Kirschner; Jennifer J Linderman
Journal:  PLoS One       Date:  2013-07-15       Impact factor: 3.240

10.  Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction.

Authors:  Claire J Greenhill; Gareth W Jones; Mari A Nowell; Zarabeth Newton; Ann K Harvey; Abdul N Moideen; Fraser L Collins; Anja C Bloom; Rebecca C Coll; Avril A B Robertson; Matthew A Cooper; Marcela Rosas; Philip R Taylor; Luke A O'Neill; Ian R Humphreys; Anwen S Williams; Simon A Jones
Journal:  Arthritis Res Ther       Date:  2014-08-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.